Table 3.
Procedure | Screening | Baseline | 1 month | 2 months | 3 months | 4 months | 5 months | 6 months | 3 years |
---|---|---|---|---|---|---|---|---|---|
Review eligibility criteria | X | X | |||||||
Written informed consent | X | ||||||||
Demographic data and medical history | X | ||||||||
Questionnaires: KDQoL, EQ-5D-5L, PSQI, SONG-HD, TTR | X | X | X | X | |||||
MoCA | X | X | X | ||||||
Baseline health economics questionnaire | X | ||||||||
Randomisation | X | ||||||||
Intradialytic urine collection and paired blood samples* | X | X | |||||||
Serum beta-2 microglobulin* | X | X | X | X | X | X | X | ||
Resource use and expenditure questionnaire | X | X | X | ||||||
Routine clinical data◊ including adherence, dialysis adequacy, blood pressure and monthly blood results | X | X | X | X | X | X | X | ||
Capture of routine clinical data and resource usage (UKRR, SRR, HES, ONS, ISD) | X |
*Blood samples drawn at the same time as routine clinical testing. ◊Routinely collected data on all dialysis units